Process View
Any apoptotic process in an endothelial cell. An endothelial cell comprises the outermost layer or lining of anatomical structures and can be squamous or cuboidal.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "endothelial cell apoptotic process"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
TEK | TEK tyrosine kinase, endothelial | 0.973 | Mouse | |
TAL1 | T-cell acute lymphocytic leukemia 1 | 0.936 | ||
CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.929 | ||
AKR1C2 | aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III) | 0.794 | Human | |
SQSTM1 | sequestosome 1 | 0.786 | ||
TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.685 | ||
FAS | Fas (TNF receptor superfamily, member 6) | 0.652 | ||
TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.634 | ||
CFLAR | CASP8 and FADD-like apoptosis regulator | 0.589 | ||
CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.589 | ||
FGB | fibrinogen beta chain | 0.551 | ||
AKR1C1 | aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase) | 0.531 | Human | |
TRADD | TNFRSF1A-associated via death domain | 0.479 | ||
COL4A2 | collagen, type IV, alpha 2 | 0.469 | Human | |
TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.423 | ||
MAFG | v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian) | 0.396 | ||
RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.392 | ||
COL4A1 | collagen, type IV, alpha 1 | 0.382 | Human | |
RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.349 | ||
TRAF1 | TNF receptor-associated factor 1 | 0.347 | ||
CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.330 | ||
FGA | fibrinogen alpha chain | 0.316 | ||
NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.303 | ||
PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.276 | ||
IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.233 | ||
ANGPT2 | angiopoietin 2 | 0.229 | Human | |
NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.225 | ||
RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.220 | ||
PLAU | plasminogen activator, urokinase | 0.204 | ||
TRAF6 | TNF receptor-associated factor 6 | 0.197 | ||
KEAP1 | kelch-like ECH-associated protein 1 | 0.194 | ||
TRAF5 | TNF receptor-associated factor 5 | 0.190 | ||
AKR1C3 | aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) | 0.183 | ||
TRAF3 | TNF receptor-associated factor 3 | 0.183 | ||
TNFRSF6B | tumor necrosis factor receptor superfamily, member 6b, decoy | 0.179 | ||
NOXA1 | NADPH oxidase activator 1 | 0.177 | ||
PARD6A | par-6 partitioning defective 6 homolog alpha (C. elegans) | 0.163 | ||
AXL | AXL receptor tyrosine kinase | 0.158 | ||
PRKCZ | protein kinase C, zeta | 0.153 | Human | |
RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.138 | ||
PLAT | plasminogen activator, tissue | 0.135 | ||
RASSF5 | Ras association (RalGDS/AF-6) domain family member 5 | 0.132 | ||
PML | promyelocytic leukemia | 0.128 | ||
BIRC3 | baculoviral IAP repeat containing 3 | 0.121 | ||
FADD | Fas (TNFRSF6)-associated via death domain | 0.114 | ||
PARD6B | par-6 partitioning defective 6 homolog beta (C. elegans) | 0.112 | ||
TRAF2 | TNF receptor-associated factor 2 | 0.104 | ||
FGG | fibrinogen gamma chain | 0.103 | ||
TNF | tumor necrosis factor | 0.102 | ||
COL4A3 | collagen, type IV, alpha 3 (Goodpasture antigen) | 0.098 | ||
PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.097 | ||
COL4A4 | collagen, type IV, alpha 4 | 0.084 | Human | |
PTPRB | protein tyrosine phosphatase, receptor type, B | 0.082 | ||
MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.080 | ||
MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.074 | ||
MAP2K5 | mitogen-activated protein kinase kinase 5 | 0.072 | ||
UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | 0.071 | ||
PARD6G | par-6 partitioning defective 6 homolog gamma (C. elegans) | 0.071 | ||
FYB | FYN binding protein | 0.066 | ||
S100B | S100 calcium binding protein B | 0.066 | ||
TNIP1 | TNFAIP3 interacting protein 1 | 0.065 | ||
CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.064 | ||
NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.061 | ||
RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 0.061 | ||
MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.061 | ||
VIM | vimentin | 0.056 | ||
ZMYND11 | zinc finger, MYND-type containing 11 | 0.054 | ||
CRP | C-reactive protein, pentraxin-related | 0.050 | ||
MAP3K1 | mitogen-activated protein kinase kinase kinase 1 | 0.049 | ||
MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | 0.049 | ||
TOX4 | TOX high mobility group box family member 4 | 0.047 | ||
TNFRSF14 | tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) | 0.047 | Human | |
PGF | placental growth factor | 0.046 | ||
COL4A5 | collagen, type IV, alpha 5 | 0.045 | Human | |
CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.045 | ||
ITGAL | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | 0.045 | ||
NUMB | numb homolog (Drosophila) | 0.045 | ||
PLAUR | plasminogen activator, urokinase receptor | 0.044 | ||
ZNF71 | zinc finger protein 71 | 0.043 | ||
ANGPT1 | angiopoietin 1 | 0.042 | ||
TNIP2 | TNFAIP3 interacting protein 2 | 0.040 | ||
VEGFA | vascular endothelial growth factor A | 0.040 | ||
PDGFA | platelet-derived growth factor alpha polypeptide | 0.039 | ||
COL5A1 | collagen, type V, alpha 1 | 0.039 | ||
FGFR1 | fibroblast growth factor receptor 1 | 0.038 | ||
VEGFC | vascular endothelial growth factor C | 0.038 | ||
LIMD1 | LIM domains containing 1 | 0.037 | ||
SPHK1 | sphingosine kinase 1 | 0.036 | ||
SMAD3 | SMAD family member 3 | 0.034 | ||
SIAH1 | seven in absentia homolog 1 (Drosophila) | 0.034 | ||
BCAR1 | breast cancer anti-estrogen resistance 1 | 0.033 | ||
LRP1 | low density lipoprotein receptor-related protein 1 | 0.033 | ||
MAP3K14 | mitogen-activated protein kinase kinase kinase 14 | 0.032 | ||
RUNX1 | runt-related transcription factor 1 | 0.031 | ||
CDCP1 | CUB domain containing protein 1 | 0.030 | ||
ARAF | v-raf murine sarcoma 3611 viral oncogene homolog | 0.030 | ||
NID1 | nidogen 1 | 0.029 | ||
NID2 | nidogen 2 (osteonidogen) | 0.028 | ||
KITLG | KIT ligand | 0.028 | ||
TBX5 | T-box 5 | 0.028 | ||
TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.028 | ||
MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.028 | ||
A2M | alpha-2-macroglobulin | 0.027 | ||
TTR | transthyretin | 0.027 | ||
CCDC115 | coiled-coil domain containing 115 | 0.027 | ||
BGN | biglycan | 0.027 | ||
TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.027 | ||
KIAA1377 | KIAA1377 | 0.027 | ||
KLF13 | Kruppel-like factor 13 | 0.027 | ||
SH3RF1 | SH3 domain containing ring finger 1 | 0.026 | ||
ZHX1 | zinc fingers and homeoboxes 1 | 0.026 | ||
PECAM1 | platelet/endothelial cell adhesion molecule | 0.025 | ||
VHL | von Hippel-Lindau tumor suppressor | 0.025 | ||
RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.025 | ||
BACH1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 | 0.024 | Human | |
TNFSF14 | tumor necrosis factor (ligand) superfamily, member 14 | 0.024 | Human | |
LAT | linker for activation of T cells | 0.024 | ||
PARD3 | par-3 partitioning defective 3 homolog (C. elegans) | 0.024 | ||
PRKCE | protein kinase C, epsilon | 0.024 | ||
COL4A6 | collagen, type IV, alpha 6 | 0.023 | Human | |
CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.023 | ||
SMG1 | SMG1 homolog, phosphatidylinositol 3-kinase-related kinase (C. elegans) | 0.023 | ||
FLT4 | fms-related tyrosine kinase 4 | 0.023 | Human | |
DAXX | death-domain associated protein | 0.023 | ||
IL32 | interleukin 32 | 0.023 | ||
RARA | retinoic acid receptor, alpha | 0.023 | ||
NMT2 | N-myristoyltransferase 2 | 0.023 | ||
CALCRL | calcitonin receptor-like | 0.023 | ||
ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.022 | ||
DCAF7 | DDB1 and CUL4 associated factor 7 | 0.021 | ||
SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.021 | ||
CD34 | CD34 molecule | 0.021 | ||
BHLHE40 | basic helix-loop-helix family, member e40 | 0.021 | ||
IRF1 | interferon regulatory factor 1 | 0.021 | ||
CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.021 | ||
PCOLCE | procollagen C-endopeptidase enhancer | 0.021 | ||
COL6A2 | collagen, type VI, alpha 2 | 0.020 | ||
ORM1 | orosomucoid 1 | 0.020 | ||
TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.020 | ||
XIAP | X-linked inhibitor of apoptosis | 0.020 | ||
NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 | 0.020 | ||
PDGFC | platelet derived growth factor C | 0.019 | ||
FYN | FYN oncogene related to SRC, FGR, YES | 0.019 | ||
C1orf93 | chromosome 1 open reading frame 93 | 0.019 | ||
LAPTM5 | lysosomal protein transmembrane 5 | 0.018 | ||
PXDN | peroxidasin homolog (Drosophila) | 0.018 | ||
PRKCA | protein kinase C, alpha | 0.017 | ||
THBS1 | thrombospondin 1 | 0.017 | ||
CAV1 | caveolin 1, caveolae protein, 22kDa | 0.017 | ||
APOA1 | apolipoprotein A-I | 0.017 | ||
CYBA | cytochrome b-245, alpha polypeptide | 0.017 | ||
CCL14 | chemokine (C-C motif) ligand 14 | 0.017 | ||
GLUL | glutamate-ammonia ligase | 0.016 | ||
FABP4 | fatty acid binding protein 4, adipocyte | 0.016 | ||
OSMR | oncostatin M receptor | 0.016 | ||
TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.016 | ||
ACTB | actin, beta | 0.016 | ||
FRZB | frizzled-related protein | 0.016 | ||
ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.016 | ||
PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.016 | Human | |
MCAM | melanoma cell adhesion molecule | 0.016 | ||
TECPR1 | tectonin beta-propeller repeat containing 1 | 0.016 | ||
COL16A1 | collagen, type XVI, alpha 1 | 0.016 | ||
LIMK2 | LIM domain kinase 2 | 0.016 | ||
PLXDC1 | plexin domain containing 1 | 0.015 | ||
ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.015 | ||
TBX2 | T-box 2 | 0.015 | ||
TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.015 | ||
FBN1 | fibrillin 1 | 0.015 | ||
STK10 | serine/threonine kinase 10 | 0.014 | ||
PICK1 | protein interacting with PRKCA 1 | 0.014 | ||
KSR1 | kinase suppressor of ras 1 | 0.014 | ||
REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.013 | ||
RIN1 | Ras and Rab interactor 1 | 0.013 | ||
VTN | vitronectin | 0.013 | ||
F2 | coagulation factor II (thrombin) | 0.013 | ||
COL1A2 | collagen, type I, alpha 2 | 0.013 | ||
MAFK | v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian) | 0.013 | ||
ZC3H12A | zinc finger CCCH-type containing 12A | 0.013 | ||
F11R | F11 receptor | 0.013 | ||
HEYL | hairy/enhancer-of-split related with YRPW motif-like | 0.013 | ||
CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.013 | ||
PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.013 | ||
MSN | moesin | 0.012 | ||
COL6A1 | collagen, type VI, alpha 1 | 0.012 | ||
ALB | albumin | 0.012 | ||
SPRR2A | small proline-rich protein 2A | 0.012 | ||
TICAM1 | toll-like receptor adaptor molecule 1 | 0.012 | ||
TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.012 | ||
CD44 | CD44 molecule (Indian blood group) | 0.012 | ||
GJA4 | gap junction protein, alpha 4, 37kDa | 0.012 | ||
ZBTB16 | zinc finger and BTB domain containing 16 | 0.012 | ||
NPR1 | natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) | 0.012 | ||
SIAH2 | seven in absentia homolog 2 (Drosophila) | 0.012 | ||
PLXND1 | plexin D1 | 0.012 | ||
RYBP | RING1 and YY1 binding protein | 0.012 | ||
WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.012 | ||
STK11 | serine/threonine kinase 11 | 0.011 | ||
MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.011 | ||
NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.011 | ||
RBCK1 | RanBP-type and C3HC4-type zinc finger containing 1 | 0.011 | ||
AKT3 | v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) | 0.011 | Human | |
IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.011 | ||
BCL3 | B-cell CLL/lymphoma 3 | 0.011 | ||
CD14 | CD14 molecule | 0.011 | ||
ACTN1 | actinin, alpha 1 | 0.011 | ||
PLCG1 | phospholipase C, gamma 1 | 0.011 | ||
HSPA6 | heat shock 70kDa protein 6 (HSP70B') | 0.011 | ||
PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.011 | Human | |
ACVRL1 | activin A receptor type II-like 1 | 0.011 | ||
ICAM1 | intercellular adhesion molecule 1 | 0.011 | ||
CD97 | CD97 molecule | 0.011 | ||
IKBKE | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon | 0.011 | ||
LMO4 | LIM domain only 4 | 0.011 | ||
AEBP1 | AE binding protein 1 | 0.011 | ||
TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.011 | ||
TRMT2A | TRM2 tRNA methyltransferase 2 homolog A (S. cerevisiae) | 0.011 | ||
KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.011 | ||
PCDH12 | protocadherin 12 | 0.011 | ||
IGFBP5 | insulin-like growth factor binding protein 5 | 0.011 | ||
SORBS2 | sorbin and SH3 domain containing 2 | 0.011 | ||
BAG1 | BCL2-associated athanogene | 0.010 | ||
CLDN5 | claudin 5 | 0.010 | ||
COL3A1 | collagen, type III, alpha 1 | 0.010 | ||
PPP1R14A | protein phosphatase 1, regulatory (inhibitor) subunit 14A | 0.010 | ||
DDAH2 | dimethylarginine dimethylaminohydrolase 2 | 0.010 | ||
HSD3B7 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 | 0.010 | ||
SLA | Src-like-adaptor | 0.010 | ||
TFPI2 | tissue factor pathway inhibitor 2 | 0.010 | ||
MYH9 | myosin, heavy chain 9, non-muscle | 0.010 | ||
SHANK3 | SH3 and multiple ankyrin repeat domains 3 | 0.010 |